| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | 0.064 | 0.04 |
| mRNA | CI-1040 | GDSC1000 | pan-cancer | AAC | -0.073 | 0.04 |
| mRNA | BRD-K48334597 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.04 |
| mRNA | FGIN-1-27 | CTRPv2 | pan-cancer | AAC | 0.16 | 0.05 |
| mRNA | PX-12 | CTRPv2 | pan-cancer | AAC | 0.066 | 0.05 |
| mRNA | ZSTK474 | CTRPv2 | pan-cancer | AAC | 0.083 | 0.05 |
| mRNA | GW843682X | CTRPv2 | pan-cancer | AAC | 0.077 | 0.05 |
| mRNA | valdecoxib | CTRPv2 | pan-cancer | AAC | 0.079 | 0.05 |
| mRNA | brivanib | CTRPv2 | pan-cancer | AAC | 0.079 | 0.05 |
| mRNA | ML311 | CTRPv2 | pan-cancer | AAC | 0.072 | 0.05 |